Minimal-uncertainty prediction of general drug-likeness based on Bayesian neural networks
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Triaging unpromising lead molecules early in the drug discovery process is essential for accelerating its pace while avoiding the costs of unwarranted biological and clinical testing. Accordingly, medicinal chemists have been trying for decades to develop metrics—ranging from heuristic measures to machine-learning models—that could rapidly distinguish potential drugs from small molecules that lack drug-like features. However, none of these metrics has gained universal acceptance and the very idea of ‘drug-likeness’ has recently been put into question. Here, we evaluate drug-likeness using different sets of descriptors and different state-of-the-art classifiers, reaching an out-of-sample accuracy of 87–88%. Remarkably, because these individual classifiers yield different Bayesian error distributions, their combination and selection of minimal-variance predictions can increase the accuracy of distinguishing drug-like from non-drug-like molecules to 93%. Because total variance is comparable with its aleatoric contribution reflecting irreducible error inherent to the dataset (as opposed to the epistemic contribution due to the model itself), this level of accuracy is probably the upper limit achievable with the currently known collection of drugs. When designing new drugs, there are countless ways to create molecules, yet only a few interact with biological targets. Beker and colleagues provide here a graph neural network based metric for drug-likeness that can guide the search.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
MoleculeNet: a benchmark for molecular machine learning
Wu, Z., Ramsundar, B., Feinberg, E. N., Gomes, J., Geniesse, C., Pappu, A. S., Leswing, K., & Pande, V. (2018) · Chemical Science · doi:10.1039/c7sc02664a · Cited by 3,107
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
Announcing the worldwide Protein Data Bank
Berman, H., Henrick, K., & Nakamura, H. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb1203-980 · Cited by 3,093
Convolutional Networks on Graphs for Learning Molecular Fingerprints
Duvenaud, D., Maclaurin, D., Aguilera-Iparraguirre, J., Gómez-Bombarelli, R., Hirzel, T., Aspuru-Guzik, A., & Adams, R. P. (2015) · arXiv · doi:10.48550/arxiv.1509.09292 · Cited by 2,628
Aleatory or epistemic? Does it matter?
Kiureghian, A. D., & Ditlevsen, O. (2009) · Structural Safety · doi:10.1016/j.strusafe.2008.06.020 · Cited by 2,454
Molecular graph convolutions: moving beyond fingerprints
Kearnes, S., McCloskey, K., Berndl, M., Pande, V., & Riley, P. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9938-8 · Cited by 1,631
A graph-convolutional neural network model for the prediction of chemical reactivity
Coley, C. W., Jin, W., Rogers, L., Jamison, T. F., Jaakkola, T. S., Green, W. H., Barzilay, R., & Jensen, K. F. (2019) · Chemical Science · doi:10.1039/c8sc04228d · Cited by 679
Kwon, Y., Won, J.-H., Kim, B. J., & Paik, M. C. (2020) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2019.106816 · Cited by 424
Cited by
Hands-On Bayesian Neural Networks—A Tutorial for Deep Learning Users
Jospin, L. V., Laga, H., Boussaid, F., Buntine, W., & Bennamoun, M. (2022) · IEEE Computational Intelligence Magazine · doi:10.1109/mci.2022.3155327 · Cited by 879
“BNNs have been used in many fields to quantify uncertainty, e . g ., in computer vision [32], network traffic monitoring [33], aviation [34], civil engineering [35, 36], hydrology [37], astronomy [38], electronics [39], and medicine [40].”
MethodDeep generative molecular design reshapes drug discovery
Zeng, X., Wang, F., Luo, Y., Kang, S.-G., Tang, J., Lightstone, F. C., Fang, E. F., Cornell, W., Nussinov, R., & Cheng, F. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100794 · Cited by 295
Uncertainty quantification: Can we trust artificial intelligence in drug discovery?
Yu, J., Wang, D., & Zheng, M. (2022) · iScience · doi:10.1016/j.isci.2022.104814 · Cited by 59
“Beker et al. systematically evaluated the performance of various AI models on the prediction of molecular drug-likeness using different types of molecular descriptors (Beker et al., 2020), where Deep Ensemble is used for uncertainty quantification.”
MethodInfluential
Metadata
- Authors
- Beker, W., Wołos, A., Szymkuć, S., & Grzybowski, B. A.
- Venue
- Nature Machine Intelligence
- Published
- 2020-08-12
- Volume
- 2
- Issue
- 8
- Pages
- 457-465
- ISSN
- 2522-5839 (ISSN-L)
- OpenAlex
- W3048788615
- Cited by
- 58
- References
- 9
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Minimal-uncertainty prediction of general drug-likeness based on Bayesian neural networks. https://app.cochat.ai/papers/10.1038/s42256-020-0209-y
- The paper
- Beker, W., Wołos, A., Szymkuć, S., & Grzybowski, B. A. (2020). Minimal-uncertainty prediction of general drug-likeness based on Bayesian neural networks. Nature Machine Intelligence. https://doi.org/10.1038/s42256-020-0209-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.